Fingerprint
Dive into the research topics of 'Longer-term Safety of B-Cell Therapy with Ocrelizumab in Multiple Sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Longer-term Safety of B-Cell Therapy with Ocrelizumab in Multiple Sclerosis
E. Ann Yeh, Dennis Bourdette, Heinz Wiendl
Research output: Contribution to journal › Editorial › peer-review